Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated:  10/30/2015
Statesboro OB/GYN Specialists
mi
from
Statesboro, GA
Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated: 10/30/2015
Statesboro OB/GYN Specialists
mi
from
Statesboro, GA
Click here to add this to my saved trials
Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated:  10/30/2015
Shaw Center for Women's Health
mi
from
Thomasville, GA
Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated: 10/30/2015
Shaw Center for Women's Health
mi
from
Thomasville, GA
Click here to add this to my saved trials
Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated:  10/30/2015
Athens OBGYN
mi
from
Athens, GA
Protecting Pregnant Women From Infectious Diseases
Protecting Pregnant Women From Infectious Diseases: a Cluster Randomized Evaluation of the Comprehensive "P3" Intervention Package Within Obstetric Practices in Georgia
Status: Enrolling
Updated: 10/30/2015
Athens OBGYN
mi
from
Athens, GA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Huntsville, AL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Anaheim, CA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
San Diego, CA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Coral Gables, FL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Hollywood, FL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Melbourne, FL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Melbourne, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
South Miami, FL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
West Palm Beach, FL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Peoria, IL
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Peoria, IL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Mishawaka, IN
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Mishawaka, IN
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Council Bluffs, IA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Newton, KA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Newton, KA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Wichita, KA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Wichita, KA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Metairie, LA
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Rockville, MD
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Edina, MN
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Edina, MN
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Bellevue, NE
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Bellevue, NE
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Omaha, NE
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Endwell, NY
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Endwell, NY
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Rochester, NY
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Cary, NC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Cary, NC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Charlotte, NC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Raleigh, NC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Wilmington, NC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Warwick, RI
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Anderson, SC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Mt. Pleasant, SC
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Dakota Dunes, SD
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Dakota Dunes, SD
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Austin, TX
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Austin, TX
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Dallas, TX
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Fort Worth, TX
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
San Angelo, TX
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
San Angelo, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
South Jordan, UT
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, NonInferiority Study to Evaluate the Safety and Immunogenicity of a Cell-based Quadrivalent Subunit Influenza Virus Vaccine and Cell-based Trivalent Subunit Influenza Virus Vaccines in Adults Ages ≥18 Years of Age
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
South Jordan, UT
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Huntsville, AL
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Mobile, AL
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Chandler, AZ
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Mesa, AZ
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Mesa, AZ
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Harrisburg, AR
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Harrisburg, AR
Click here to add this to my saved trials
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Jonesboro, AR
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
A Phase III, Stratified, Randomized, Double-Blind, Multicenter, Non-Inferiority Study to Evaluate Safety and Immunogenicity of Cell-Based Quadrivalent Subunit Influenza Virus Vaccine and Cell-Based Trivalent Subunit Influenza Virus Vaccines in Subjects Ages ≥4 Years to < 18 Years
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials